首页> 外文期刊>The regulatory affairs journal: Pharma >Medicines Counterfeiting in Egypt
【24h】

Medicines Counterfeiting in Egypt

机译:埃及的药品假冒

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The Egyptian Ministry of Health (MoH) is concerned about the continuing and increasing risk to public health posed by counterfeit medicines and is putting increased effort into implementing the country's counterfeiting laws. The market for pharmaceuticals is flourishing in Egypt and the circulation of poor quality, harmful and counterfeit active ingredients and finished products is seen as seriously reducing the quality of patient healthcare, and possibly life-threatening. There are several reasons why the counterfeit market is healthy. Counterfeiting is a lucrative business, counterfeiters take advantage of poor, uneducated patients who cannot afford the costs of registered medicines and those concerned are usually reluctant to report, to avoid involvement in lengthy investigations.
机译:埃及卫生部(MoH)对假冒药品对公共健康的持续和日益增加的风险表示关注,并正在加大力度实施该国的假冒法律。埃及的药品市场蓬勃发展,劣质,有害和伪造的活性成分和制成品的流通被认为严重降低了患者医疗质量,并可能危及生命。假冒市场健康的原因有很多。假冒是一项有利可图的业务,假冒者利用无法负担已注册药品费用的贫困,未受过教育的患者,而有关人员通常不愿举报,以避免参与冗长的调查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号